ClinicalTrials.Veeva

Menu

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

University of California (UC) Davis logo

University of California (UC) Davis

Status

Completed

Conditions

Keratosis, Actinic

Treatments

Radiation: Blue Light
Device: Microneedle Roller
Drug: Aminolevulinic Acid

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

Full description

The current standard of care of photodynamic therapy to treat actinic keratoses includes pre-treatment of the area with topical aminolevulinic acid for 1 hour, followed by treatment with blue light. In a previous study, the investigators showed pretreatment of microneedles enhance penetration of topical aminolevulinic acid as compared to the control group.

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

Enrollment

32 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age and older
  • Subjects has actinic keratoses and qualifies for photodynamic therapy
  • Do not meet any of the exclusion criteria

Exclusion criteria

  • Subjects who smoke
  • Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition
  • Subjects who have established allergy to topical ALA
  • Subjects who have had a documented nonmelanoma skin cancer on the face over the past 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups

10-minute Incubation with Microneedle Roller & Sham
Experimental group
Description:
10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.
Treatment:
Radiation: Blue Light
Drug: Aminolevulinic Acid
Device: Microneedle Roller
20-minute Incubation with Microneedle Roller & Sham
Experimental group
Description:
20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.
Treatment:
Radiation: Blue Light
Drug: Aminolevulinic Acid
Device: Microneedle Roller

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems